Cited by 3RNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryBarrier Structure and Function Studies

Multiplex screening of transferrin receptor-targeted lipid nanoparticles for systemic brain delivery using DNA barcodes

Open access
Ghosh, Soumitra, Fan, Yuchen, Laufer, Benjamin I., Stephenson, William, Zang, Nanzhi, Lawrence, Jessica, Lin, Han H., Sen, Sanjana +10 more·2026·Cell Biomaterials

Abstract

Lipid nanoparticle (LNP) encapsulation has shown strong potential for delivering nucleic acid-based medicines (NABMs); however, effective delivery to the central nervous system (CNS) remains challenging. Here, we combined high-throughput screening (HTS) with a targeting antibody fragment (Fab) against the transferrin receptor—a clinically validated mediator of blood-brain barrier (BBB) transcytosis—to rapidly identify LNPs capable of accessing brain parenchyma from systemic circulation. A library of 23 LNPs, each with distinct Fab densities and a unique DNA barcode, was evaluated via a single intravenous injection. Brain and liver biodistribution were quantitatively assessed using PCR and amplicon sequencing, with in situ hybridization and immunofluorescence confirming barcode presence in the brain. The results revealed that Fab density and lipid composition were critical for CNS partitioning. The work described here demonstrates how integrating clinically translatable ligands and in vivo HTS can guide the rational design of LNPs, with the potential to accelerate the discovery of LNP formulations that target the CNS parenchyma.

Integrity signals

Registry

Crossref · 10.1016/j.celbio.2025.100303

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Canadian Agency for Drugs and Technologies in Health (2019). Clinical Review Report: Patisiran (Onpattro): (Alnylam Netherlands B.V.): Indication: Treatment of polyneuropathy in adult patients with hereditary transthyretin-mediated amyloidosis. https://www.cda-amc.ca/sites/default/files/cdr/clinical/sr0598-onpattro-clinical-review-report.pdf,

Cited by

Still being checked.

Authors
Ghosh, S., Fan, Y., Laufer, B. I., Stephenson, W., Zang, N., Lawrence, J., Lin, H. H., Sen, S., Miller, S. E., Chu, S., Imperio, J., Lubeck, E., Yen, C.-W., Meilandt, W. J., Monson, S., Bingol, B., Friedman, B. A., & Shatz-Binder, W.
Affiliations
Genentech
Corresponding author
  • Ghosh, Soumitra
  • Shatz-Binder, Whitney
Venue
Cell Biomaterials
Publisher
Elsevier BV
Published
2026-03
Volume
2
Issue
3
Pages
100303
ISSN
3050-5623 (ISSN-L)
OpenAlex
W7117449321
Cited by
3
References
64
Citations by year
2026: 3
FWCI
0.76
Type
journal article
Language
en
Open access
Locations
Cell Biomaterials (publishedVersion, cc-by-nc-nd)
Funders
Genentech Inc
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
lipid nanoparticles, transferrin receptor, blood-brain barrier, brain drug delivery, DNA barcodes, high-throughput screening, lipid composition, tissue distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review